Centre for Commercialization of Regenerative Medicine
The Centre for Commercialization of Regenerative Medicine (CCRM) is a network that bridges the regenerative medicine (RM) commercialization gap by leveraging funding and infrastructure, and mobilizing business and scientific expertise to translate technologies into commercial products and therapies. CCRM was launched on June 14th 2011 and brings together visionary business leadership and unique technology development platforms to commercialize promising discoveries in stem cell and biomaterial science through a capital-efficient, collaborative model.
CCRM offers a business development team that rigorously evaluates technologies with a view towards company creation. Combined with its three platforms – Cell Reprogramming and Engineering, Cell Manufacturing, and Biomaterials and Devices, CCRM works to commercialize discoveries in these areas and move new ideas from the lab to the marketplace. The office, located at the Banting Institute at the University of Toronto, has a 6,000 square foot development facility to house the three platforms.
CCRM is a Canadian not-for-profit, public-private consortium funded by the Government of Canada’s Networks of Centres of Excellence program, six Ontario-based institutional partners and more than 40 companies representing the key sectors of the regenerative medicine industry.